NOTE: You MUST buy a ticket through Eventbrite to attend. Your registration on Partiful does not give you event access.
Purchase your ticket here: https://www.eventbrite.com/e/ai-x-longevity-nyc-tickets-1987706522717
--
AI is rapidly reshaping how we understand and intervene on aging.
From target discovery and biomarker development to clinical decision-making and patient monitoring, AI is now embedded across the longevity stack. At the same time, much of the conversation is still disconnected from the realities of biology, data quality, and clinical translation.
The field is moving quickly, but not always clearly.
AI x Longevity NYC is designed around this moment.
As the inaugural NYC Chapter summit from Longevity Global, this event brings together a highly curated group of founders, scientists, clinicians, operators, and investors working at the intersection of AI and human healthspan.
The focus is not on high-level narratives. It is on what is actually being built, what is working, and what still needs to be solved.
You can find information on this year's speakers and pitch competition here:
https://longevitygl.org/nyc-ai-x-longevity-summit/
What Will Be Covered
Day 1: Intelligence → Biology → Strategy
Day 1 is centered on how AI is being applied to biological systems and what that means for discovery and company building.
Discussions will focus on:
How AI is being used in drug discovery, target identification, and biomarker development
The role of data quality, experimental design, and infrastructure in enabling meaningful AI outputs
Where models are delivering real signal versus where they are still limited
How companies are structuring around AI, including platform strategy, data acquisition, and differentiation
The investment landscape around AI x Bio and how capital is being deployed
The goal is to ground AI in the realities of biology and connect technical capability to real strategic decisions.
Day 2: Clinical → Systems → Scale
Day 2 shifts to how AI is being deployed in clinical and patient-facing environments and what it takes to scale.
Discussions will focus on:
AI in longevity clinics and preventative care models
Integration of digital health, continuous monitoring, and real-world data
Clinical decision support and personalized intervention strategies
Regulatory and policy considerations at the intersection of AI and healthcare
What it takes to move from model to deployment across real patient populations
Day 2 also features:
Live pitch competition finals for Seed and Series A companies building at the intersection of AI and longevity, with prizes and support from BioLabs at NYU Langone
Direct interaction between founders, investors, clinicians, and pharma teams evaluating AI-driven approaches
[AGENDA AND SPEAKER LINEUP COMING SOON]
Who This Is For
This is a space for people actively building and deploying at this intersection:
Scientists applying AI to aging biology and disease
Founders building AI-driven therapeutics, platforms, and diagnostics
Investors focused on AI x Bio and digital health
Clinicians and operators integrating AI into care models
Pharma and BD teams evaluating new technologies
Engineers and data scientists working on real biological and clinical systems
The format is intentionally designed to prioritize meaningful interaction over scale, creating an environment where conversations go deeper and connections are more relevant.
--
This event is a part of #NYTechWeek—a week of events hosted by VCs and startups to bring together the tech ecosystem. Learn more at www.tech-week.com.
Guest List
1 on the list
◔◟◔
>.<
:◗
Restricted Access
Must be on the list to view event activity & see list details